A judge has dismissed jailed property developer Salim Mehajer’s defamation lawsuit against broadcaster Seven, saying delays in fixing significant defects in his case amounted to an abuse of process.
Sydney’s ongoing COVID-19 lockdown has created “logistical” difficulties delaying the release of a long awaited judgment in the ACCC’s consumer law case against collapsed private college Phoenix Institute, which was accused of misleading students through the marketing of its courses.
Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival’s claims.
Six of Australia’s biggest financial services firms have paid or offered to pay a total of $1.86 billion to customers who were wrongly charged fees for no service or were given bad advice.
A controversial announcement by Victorian-based fruit and vegetable processor SPC that it will mandate COVID-19 vaccines for all of its 450 onsite workers could face legal challenges on several grounds.
The Star Entertainment Group will not be able to recoup losses at its casinos and hotels stemming from the COVID-19 pandemic, after a judge found the company’s $4 billion industrial special risks policy did not cover financial losses from government-imposed restrictions.
Australian software company TechnologyOne has succeeded in its challenge to a $5.2 million judgment in an unfair dismissal case by a former high ranking executive, with an appeals court sending the matter back for a retrial.
A New Zealand-based association representing manuka honey beekeepers has lost its opposition to an application for the ‘Australian Manuka’ trade mark by a Byron Bay honey producer, with IP Australia finding the word ‘manuka’ did not specifically refer to honey made in NZ.
Food and beverage manufacturer Freedom Foods will call its CEO and ex-group chairman to the stand in a case filed by the firm’s former group general counsel, who has dropped her lawyer and is now self-represented.
The Australian Securities and Investments Commission has filed court action against a multi-million dollar Western Australian biotech company, alleging it made several misleading representations to the market during the height of the COVID-19 pandemic.